Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|August 13, 2024
Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patientsCarine Dufau, Matthieu Genais, Elodie Mucher, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2009
FAN stimulates TNF(alpha)-induced gene expression, leukocyte recruitment, and humoral responseAnne Montfort, Bénédicte de Badts, Victorine Douin-Echinard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical TrialAnne Montfort, Thomas Filleron, Mathieu Virazels, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian MetastasesAnne Montfort, Oliver Pearce, Eleni Maniati, et al.The Journal of Clinical Investigation|January 31, 2017
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancerChiara Berlato, Moddasar N Khan, Tiziana Schioppa, et al.International Journal of Cancer|March 18, 2025
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical studyMathieu Virazels, Amélie Lusque, Stéphanie Brayer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous CarcinomaSteffen Böhm, Anne Montfort, Oliver M T Pearce, et al.Nature Communications|January 25, 2020
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1Caroline Imbert, Anne Montfort, Marine Fraisse, et al.Cancer Discovery|December 3, 2017
Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human CancersOliver M T Pearce, Robin M Delaine-Smith, Eleni Maniati, et al.Cancer Immunology Research|March 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy EfficacyAnne Montfort, Florie Bertrand, Julia Rochotte, et al.Pageof 2